IP Library Granted Patent US 7,749,371
Granted Patent B2
US 7,749,371 · App. 11/240,797 · Granted Jul 6, 2010

Method and apparatus for rapid electrochemical analysis

Assignee: LifeScan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,749,371
App. No.
11/240,797
Granted
Jul 6, 2010
Kind
B2
Abstract

Methods and apparatus for electrochemically determining an analyte concentration value in a physiological sample are disclosed. The methods include using a test strip in which two time-current transients are measured by a meter electrically connected to an electrochemical test strip. Integrative current values are derived from the time-current transients and used in the calculation of analyte concentration.

Claims (60)

1. A method for determining an analyte concentration in a physiological sample, the method comprising:

(a) introducing the physiological sample into an electrochemical cell, the electrochemical cell comprising:

(i) first and second electrodes in a spaced apart relationship; and

(ii) a reagent layer comprising an enzyme and a mediator;

(b) applying a first electric potential having a first polarity to the electrochemical cell and measuring cell current as a function of time to obtain a first time-current transient;

(c) applying a second electric potential having a second polarity to the cell, wherein the second polarity is opposite the first polarity, and measuring cell current as a function of time to obtain a second time-current transient; and

(d) calculating a first current value from the second time-current transient;

(e) calculating a second current value from the second time-current transient and a third current value from the first time-current transient;

(f) calculating a ratio which comprises the second current value divided by the third current value; and

(g) multiplying the first current value less a background value by said ratio to derive analyte concentration.

2. The method according to claim 1 , wherein steps (b) through (g) occur in less than about 5 seconds to less than about 10 seconds.

3. The method according to claim 1 , wherein said ratio is to a power p.

4. The method according to claim 1 , wherein the analyte concentration is calculated based upon an equation [C]=(I 2 /I 3 ) P *((a*I 1 )−Z) where [C] is analyte concentration, I 1 is the first current value, I 2 is the second current value, I 3 is the third current value, and Z, p and a are calibration factors.

5. The method according to claim 4 , wherein p is in the range of about 0.2 and 4.

6. The method according to claim 5 , wherein p is equal to one and a is equal to one.

7. The method according to claim 4 , further comprising the step of empirically determining p and a.

8. The method according to claim 1 , wherein the first current value is proportional to analyte concentration.

9. The method according to claim 1 , wherein the first, second, and third current values comprise an integral of cell current as a function of time.

10. The method according to claim 1 , wherein the first, second, and third current values comprise a summation of cell current.

11. The method according to claim 1 , wherein the analyte is glucose.

12. The method according to claim 1 , wherein the physiological sample is a material selected from the group consisting of whole blood, plasma, serum, interstitial fluid, and urine.

13. The method according to claim 1 , wherein the first electrode and the second electrode comprise a conductive material chosen from the group consisting of gold, palladium, platinum, silver, iridium, doped tin oxide, and carbon.

14. The method according to claim 13 , wherein the first electrode is palladium and the second electrode is gold.

15. The method according to claim 13 , wherein the conductive material is sputtered onto an insulating sheet.

16. The method according to claim 13 , wherein the conductive material is screen-printed onto an insulating sheet.

17. The method according to claim 1 , wherein the reagent layer is disposed on the first electrode.

18. The method according to claim 17 , wherein the first polarity is negative with respect to the second electrode and the second polarity is positive with respect to the second electrode.

19. The method according to claim 17 , wherein the first electric potential ranges from about 0.0 to −0.6 V with respect to the second electrode and the second electric potential ranges from about 0.0 to 0.6 V with respect to the second electrode.

20. The method according to claim 1 , wherein the second electric potential is applied immediately following the application of the first electric potential.

21. The method according to claim 1 , wherein the electrochemical cell has a volume which is less than about 1 microliter.

22. The method according to claim 1 , wherein the enzyme is a material chosen from the group consisting of glucose oxidase, glucose dehydrogenase based on a methoxatin co-factor, and glucose dehydrogenase based on a nicotinamide adenine dinucleotide co-factor.

23. The method according to claim 1 , wherein the mediator is a material chosen from the group consisting of ferricyanide, ferrocene, ferrocene derivatives, osmium bipyridyl complexes, and quinone derivatives.

24. The method according to claim 1 , wherein the first electric potential is applied for a duration of time ranging from about 1 second to about 5 seconds.

25. The method according to claim 1 , wherein the second electric potential is applied for a duration of time ranging from about 1 second to about 5 seconds.

26. The method according to claim 1 , wherein the second and third current values are calculated at different time intervals.

27. A method for determining an analyte concentration in a physiological sample, the method comprising:

(a) introducing the physiological sample into an electrochemical cell, the electrochemical cell comprising:

(i) first and second electrodes in a spaced apart relationship; and

(ii) a reagent layer comprising an enzyme and a mediator;

(b) applying a first electric potential having a first polarity to the electrochemical cell and measuring cell current as a function of time to obtain a first time-current transient;

(c) applying a second electric potential having a second polarity to the cell, wherein the second polarity is opposite the first polarity, and measuring cell current as a function of time to obtain a second time-current transient; and

(d) calculating a first integrative current value from the first time-current transient and a second integrative current value from the second time-current transient;

(e) calculating a ratio which comprises the second integrative current value divided by the first integrative current value;

(f) calculating a correction factor that comprises said ratio;

(g) calculating an initial concentration value from the first and/or second time-current transients;

(h) multiplying the initial concentration value less a background value by the correction factor to derive the analyte concentration.

28. The method according to claim 27 , wherein the first and second integrative current values comprise an integral of cell current as a function of time.

29. The method according to claim 27 , wherein the first and second integrative current values comprise a summation of cell current as a function of time.

30. The method according to claim 27 , wherein the analyte is glucose.

31. The method according to claim 27 , wherein the physiological sample is a material selected from the group consisting of whole blood, plasma, serum, interstitial fluid, and urine.

32. A method for determining an analyte concentration in a physiological sample, the method comprising:

(a) introducing the physiological sample into an electrochemical cell, the electrochemical cell comprising:

(i) first and second electrodes in a spaced apart relationship; and

(ii) a reagent layer comprising an enzyme and a mediator;

(b) applying a first electric potential having a first polarity to the electrochemical cell and measuring cell charge as a function of time to obtain a first time-charge transient;

(c) applying a second electric potential having a second polarity to the cell, wherein the second polarity is opposite the first polarity, and measuring cell charge as a function of time to obtain a second time-charge transient;

(d) calculating a first charge value from the second time-charge transient;

(e) calculating a second charge value from the second time-charge transient and a third charge value from the first time-charge transient;

(f) calculating a ratio based on the second charge value and the third charge value; and

(g) multiplying the first charge value less a background value by said ratio to derive analyte concentration.

Assignments (18)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2026
From: LIFESCAN GLOBAL CORPORATION; LIFESCAN CHINA, LLC; LIFESCAN IP HOLDINGS, LLC
To: LIFESCAN ENTERPRISES LLC
Reel/Frame 075848/0012 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: ANKURA TRUST COMPANY, LLC
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0495 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073929/0316 →
SECURITY INTEREST Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: ACQUIOM AGENCY SERVICES LLC, AS COLLATERAL AGENT
Reel/Frame 073890/0305 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2025
From: WILMINGTON SAVINGS FUND SOCIETY, FSBWILMINGTON SAVINGS FUND SOCIETY, FSB
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 073928/0626 →
SECURITY AGREEMENT Recorded Dec 8, 2025
From: LIFESCAN ENTERPRISES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 073893/0622 →
ASSIGNMENT OF PATENT SECURITY INTERESTS (1ST LIEN) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 072567/0482 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 063740, FRAME 0080 Recorded Nov 12, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SUCCESSOR AGENT
Reel/Frame 069340/0243 →
TRANSFER OF SECURITY AGREEMENT RECORDED AT REEL 047179, FRAME 0150 Recorded Nov 11, 2024
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: ANKURA TRUST COMPANY, LLC, AS SUCCESSOR AGENT
Reel/Frame 069314/0022 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY LIST BY ADDING PATENTS 6990849;7169116; 7351770;7462265;7468125; 7572356;8093903; 8486245;8066866;AND DELETE 10881560. PREVIOUSLY RECORDED ON REEL 050836 FRAME 0737. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2023
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 064782/0443 →
RELEASE OF SECOND LIEN PATENT SECURITY AGREEMENT RECORDED OCT. 3, 2018, REEL/FRAME 047186/0836 Recorded Jun 28, 2023
From: BANK OF AMERICA, N.A.
To: LIFESCAN IP HOLDINGS, LLC; JANSSEN BIOTECH, INC.; JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 064206/0176 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded May 23, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063740/0080 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded May 22, 2023
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A.
Reel/Frame 063712/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CILAG GMBH INTERNATIONAL
To: LIFESCAN IP HOLDINGS, LLC
Reel/Frame 050837/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LIFESCAN INC.
To: CILAG GMBH INTERNATIONAL
Reel/Frame 050836/0737 →
SECURITY AGREEMENT Recorded Oct 3, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047186/0836 →
SECURITY AGREEMENT Recorded Oct 2, 2018
From: LIFESCAN IP HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 047179/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2006
From: GUO, SHERRY; HODGES, ALASTAIR; CHATELIER, RONALD; ZHANG, BIN
To: LIFESCAN, INC.
Reel/Frame 017465/0632 →
Continuity (1)
Related Publication 20070074977A1 · Apr 5, 2007